临床前研究表明 ,美国 BD技术公司和陆军正在研制的粉末状炭疽疫苗可在生物恐怖攻击时为保护普通人群和战场上的士兵提供一种更快捷方便的方法。　　目前的炭疽疫苗是由炭疽杆菌制成的液体疫苗 ,于 1 8个月内皮下和肌肉注射 6剂 ,并建议以后每年加强注射。但是这种方法用于大规 Preclinical studies have shown that powdered anthrax vaccines being developed by BD Technologies and the Army can provide a quick and easy way to protect the general population and soldiers on the battlefield during a bioterrorist attack. The current anthrax vaccine is a liquid vaccine made of Bacillus anthracis and is administered subcutaneously and intramuscularly for 6 doses over a period of 18 months and recommends that it be boosted annually thereafter. But this method is used for large format